🔎 Trials Near Me

Akèy › Neoplazmi myeloproliferatif › Maryland › Baltimore

Etid klinik pou Neoplazmi myeloproliferatif nan Baltimore, MD

7 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • John Hopkins Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Johns Hopkins Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · 8 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Neoplazmi myeloproliferatif nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.